Cargando…
Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial
BACKGROUND: The costs for treating coronary artery disease (CAD) are high worldwide. We performed a prespecified analyses of cost-effectiveness of three therapeutic strategies for multivessel CAD. METHODS: From May 1995 to May 2000, a total of 611 patients were randomly assigned to coronary artery b...
Autores principales: | Brandão, Sara Michelly Gonçalves, Rezende, Paulo Cury, Rocca, Hans-Peter Brunner-La, Ju, Yang Ting, de Lima, Antonio Carlos Pedroso, Takiuti, Myrthes Emy, Hueb, Whady, Bocchi, Edimar Alcides |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215652/ https://www.ncbi.nlm.nih.gov/pubmed/30410425 http://dx.doi.org/10.1186/s12962-018-0158-z |
Ejemplares similares
-
Utility and quality-adjusted life-years in coronary artery disease: Five-year follow-up of the MASS II trial
por: Brandão, Sara Michelly Gonçalves, et al.
Publicado: (2017) -
A review of cost-effectiveness analysis: From theory to clinical practice
por: Michelly Gonçalves Brandão, Sara, et al.
Publicado: (2023) -
Association Between Stress Testing–Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease
por: Garzillo, Cibele Larrosa, et al.
Publicado: (2019) -
Myocardial injury in diabetic patients with multivessel coronary artery disease after revascularization interventions
por: Rezende, Paulo Cury, et al.
Publicado: (2017) -
Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease
por: Rahmi, Rosa Maria, et al.
Publicado: (2013)